Studies have shown that PD-L1 was highly expressed in ovarian cancer, melanoma, non-small-cell lung cancer, renal cell cancer, and other tumors, and the expression of PD-1 in CD8+T cells infiltrated in tumor sites is higher than that in peripheral blood [72–75]. This evidence concerns the gene PDCD1 and melanoma.